Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with C
Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
---|---|---|---|---|---|---|---|
Q1 2024 | CALCIUM CHLORIDE | INTRA-ARTERIAL | INJECTION | NA | 10mg | Deletion | |
Q4 2023 | CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | LOTION | 0.70 %w/w | MDE Replacement | ||
Q1 2024 | CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | LOTION | 43mg | MDE Replacement | ||
Q4 2023 | CELLULOSE ACETATE | ORAL | CAPSULE | 22.15 mg | MDE Replacement | ||
Q1 2024 | CELLULOSE ACETATE | ORAL | CAPSULE | 186mg | MDE Replacement | ||
Q4 2023 | CITRIC ACID MONOHYDRATE | TOPICAL | GEL | 0.56 %w/w | MDE Replacement | ||
Q1 2024 | CITRIC ACID MONOHYDRATE | TOPICAL | GEL | 1mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024